跳至主要内容
临床试验/NCT00842959
NCT00842959已完成4 期

Check of Optical Features and Accuracy of the Zeiss ZO Lens of the Company Carl Zeiss Meditec After Selection and Calculation With OKULIX

Carl Zeiss Meditec AG1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2009年2月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
120
试验地点
1
主要终点
Accuracy of prediction of target refraction

研究概览

简要总结

It is planned to implant the intraocular lenses XL Stabi ZO and Invent ZO into the eyes of patients for whom a cataract operation is medically indicated. The lenses are marketed and CE certified. Their implantation is clinical routine.

In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Indication for cataract operation
  • •Written informed consent of patient after information

排除标准

  • •Immobility
  • •Limited capacity of understanding
  • •Diseases that hamper a follow-up examination
  • •Astigmatism >2.0 D
  • •Patients with ocular diseases who may be expected to show a vision of less than 0.63 (decimal) two months after cataract surgery with implantation of intraocular lens
  • •Complications during surgery, especially complications with positioning of the intraocular lens and with capsulorhexis

研究组 & 干预措施

ZO

Other

XL Stabi ZO or Invent ZO

干预措施: Invent ZO (Device)

ZO

Other

XL Stabi ZO or Invent ZO

干预措施: XL Stabi ZO (Device)

结局指标

主要结局

Accuracy of prediction of target refraction

时间窗: postop.

Difference between calculated and measured contrast vision.

时间窗: postop.

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验